American Renal Associates (ARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 822,522 | 805,776 | 729,002 | 766,780 | 652,981 |
| Cost of Goods | 610,179 | 570,009 | 483,101 | 452,453 | 390,949 |
| Gross Profit | 212,343 | 235,767 | 245,901 | 314,327 | 262,032 |
| Operating Expenses | 160,849 | 180,454 | 155,794 | 171,254 | 112,131 |
| Operating Income | 51,673 | 55,322 | 90,208 | 143,526 | 150,850 |
| Interest Expense | 43,587 | 32,632 | 29,309 | 35,959 | 45,400 |
| Other Income | 221 | 2,673 | 6,708 | -3,422 | 0 |
| Pre-tax Income | 8,307 | 25,363 | 67,607 | 104,145 | 105,450 |
| Income Tax | -17,838 | 2,896 | 9,471 | 2,479 | 12,373 |
| Net Income Continuous | 26,145 | 22,467 | 58,136 | 101,666 | 93,077 |
| Minority Interests | 39,935 | 51,234 | 62,733 | 98,520 | 74,232 |
| Net Income | $-13,790 | $-28,767 | $-4,597 | $3,146 | $18,845 |
| EPS Basic Total Ops | -0.68 | -0.98 | -0.52 | -0.25 | 0.85 |
| EPS Basic Continuous Ops | 0.81 | 0.70 | 1.87 | 3.62 | 4.20 |
| EPS Diluted Total Ops | -0.68 | -0.98 | -0.52 | -0.25 | 0.83 |
| EPS Diluted Continuous Ops | 0.81 | 0.70 | 1.87 | 3.62 | 4.10 |
| EPS Diluted Before Non-Recurring Items | 0.26 | N/A | 0.61 | 0.96 | N/A |
| EBITDA(a) | $98,263 | $97,105 | $129,873 | $179,983 | $185,584 |